Adults over 60 require lower starting doses, pre-treatment cancer screening, glucose monitoring, and more frequent follow-up than younger patients
doi: 10.1158/0008-5472.Can-04-0919 185 LiSWangNBrodtP
USA TESTED USA FULFILLED $52.50 View Certificate of Analysis (Batch RL-2607-0101) Independently tested Purity: 99.35% Method: HPLC RESEARCH USE DISCLAIMER This product is intended solely for laboratory research use
However, what we undoubtably observe is that ovarian cancer cells that are better adapted to cysteine are more resistant to carboplatin effects mainly in hypoxia
Unmodified mRNA can induce Toll-like receptor-mediated immune responses, leading to blocked protein synthesis
Faverzani JL, Guerreiro G, Hammerschmidt TG, Lopes FF, Coelho D, de Sitta M